Global Biopharmaceuticals Market Outlook to 2027
Segmented By Product Type (Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormone, Vaccines, Synthetic Immunomodulators, Other), Service (Laboratory Testing, Custom Testing / Customer Proprietary Testing, Compendial and Multi Compendial Laboratory Testing), Application (Oncology, Inflammatory and Infectious Diseases, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, Cardiovascular Diseases, Neurological Diseases, Other)
June 2023
70
About the Report
About the Report
The report provides a comprehensive analysis of the potential of Global Biopharmaceuticals. The report covers an overview and genesis of the industry, market size in terms of revenue generated.
The report has market segmentation which includes segments By Product Type (Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormone, Vaccines, Synthetic Immunomodulators, Other), Service (Laboratory Testing, Custom Testing / Customer Proprietary Testing, Compendial and Multi Compendial Laboratory Testing), Raw Material Type (Formulation Excipients, Active Pharmaceutical Ingredients (API), Compendial Methods (USP / EP / JP) Based Vendor Qualification Program Support), Application (Oncology, Inflammatory and Infectious Diseases, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, Cardiovascular Diseases, Neurological Diseases, Other). The report includes Porter’s five force analysis, growth enablers, recent trends & developments, pain points & solutions. The report concludes with future market projections of each market segmentation and analyst recommendations.
Market Overview
According to Ken Research estimates, the Global Biopharmaceuticals Market which grew at a robust CAGR from 2017-2022 & is forecasted to grow steadily from 2022-2027 driven by increase in chronic illness cases, innovative technologies alongside growing inorganic growth strategies.
- Governments across the world are implementing supportive regulations and policies to encourage the development and commercialization of biopharmaceutical products.
- The biopharmaceutical industry is witnessing rapid technological advancements, including the development of novel drug delivery systems, gene therapies, and personalized medicine. These advancements are driving innovation and improving the efficacy and safety of biopharmaceutical products.
Key Trends by Market Segment:
By Product: Monoclonal antibodies are estimated to hold the largest market share owing to the exponential research and applications within the oncology department.
By Service: On the basis of service, the biopharmaceuticals market is segmented into laboratory testing, custom testing / customer proprietary testing, compendial and multi compendial laboratory testing. Laboratory Testing is expected to capture the largest share of market.
Competitive Landscape
The Global Biopharmaceuticals market is moderately fragmented with players occupying almost half of the market. The key players operating in the market are not only competing based on product quality and promotion but are also focusing on strategic moves to hold larger market shares. The major companies dominating the Global Biopharmaceuticals market for its products, services, and continuous product developments are the basis of flexibility and price, brand recognition, quality, and the overall variety of the product offering among others.
Future Outlook
The Global Biopharmaceuticals Market witnessed significant growth during the period 2017-2022, owing to increase in chronic illness cases, enhancing service offerings alongside increase in product innovativeness.
Growth rate of the market is going to increase over the period as market penetration rates increase.
Scope Of The Report
Scope of the Report
|
Global Biopharmaceuticals Market Segmentation |
|
|
By Type of Product |
Monoclonal Antibodies Recombinant Growth Factors Purified Proteins Recombinant Hormones Vaccines Synthetic Immunomodulators Others |
|
By Service |
Laboratory testing Custom Testing Compendial Laboratory testing |
|
By Geography |
Asia Pacific Middle East North America Australia South America Europe |
|
By Type of Raw material |
Formulation Excipients Active Pharmaceutical Ingredients Compendial Methods
|
|
By Application |
Oncology Inflammatory & Infectious Diseases Autoimmune Disorders Metabolic Disorders Hormonal Disorders Cardiovascular Diseases Neurological Diseases Others |
Products
Products
Key Target Audience:
- Government
- Hospitals
- Clinics
- Others
Time Period Captured in the Report:
- Historical Period:2017- 2022
- Base Year: 2022
- Forecast Period: 2022-2027
Companies
Companies Covered:
- Johnson & Johnson
- Pfizer
- Novartis
- Merck & Co
- Amgen
- Bayer
- Roche
- Cipla
Table of Contents
Table of Contents
1. Executive Summary
2. Market Overview
2.1 Taxonomy of Global Biopharmaceuticals Market
2.2 Industry Value Chain
2.3 Ecosystem
2.4 Government Regulations/Initiatives for Global Biopharmaceuticals Market
2.5 Growth Drivers of Global Biopharmaceuticals Market
2.6 Issues and Challenges of Global Biopharmaceuticals Market
2.7 Impact of COVID-19 on Global Biopharmaceuticals Market
2.8 PESTLE/SWOT Analysis
3. Global Biopharmaceuticals Market Size, 2017 – 2022
4. Global Biopharmaceuticals Market Segmentation
4.1 By Product Type, 2017 - 2022
4.2 By End-User, 2017 - 2022
4.3 By Regional Split (North America/Europe/Asia-Pacific/LAMEA), 2017 - 2022
5. Competitive Landscape
5.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
5.2 Strategies Adopted by Leading Players
5.3 Company Profiles – (Top 5 - 7 Major Players)
5.3.1 Johnson & Johnson
5.3.2 Pfizer
5.3.3 Novartis
5.3.4 Merck & Co
5.3.5 Amgen
5.3.6 Bayer
5.3.7 Roche
6. Global Biopharmaceuticals Future Market Size, 2022 – 2027
7. Global Biopharmaceuticals Future Market Segmentation
7.1 By Product Type, 2022 - 2027
7.2 By End-User, 2022 - 2027
7.3 By Regional Split (North America/Europe/Asia-Pacific/LAMEA), 2022 - 2027
8. Analyst Recommendations
9. Research Methodology
10. Disclaimer
11. Contact Us
Research Methodology
Research Methodology
Step 1: Identifying Key Variables:
Ecosystem creation for all the major entities and referring to multiple secondary and proprietary databases to perform desk research around market to collate industry level information.
Step 2: Market Building:
Collating statistics on biopharmaceuticals over the years, penetration of medical services and medicines ratio to compute overall revenue generated for biopharmaceuticals.
Step 3: Validating and Finalizing:
Building market hypothesis and conducting CATIs with industry exerts belonging to different companies to validate statistics and seek operational and financial information from company representatives.
Step 4: Research output:
Our team will approach multiple biopharmaceuticals providing channels and understand nature of product segments and sales, consumer preference and other parameters, which will support us validate statistics derived through bottom to top approach from biopharmaceuticals providers.
Frequently Asked Questions
Frequently Asked Questions
01 How big is the Global Biopharmaceuticals Market?
The global biopharmaceuticals market size was exhibited at USD 300 billion in 2022 and is expected to hold around USD 700 billion by 2027.
02 Who are the major Players in Global Biopharmaceuticals Market?
Johnson & Johnson, Pfizer, Novartis, Merck & Co and Amgen are the major companies operating in the Biopharmaceuticals Market.
03 What factors are driving the Global Biopharmaceuticals Market?
Increasing chronic illness cases, active inorganic growth strategies alongside growing innovativeness are some of the major growth drivers of Global Biopharmaceuticals.
04 Which is the fastest growing region in Biopharmaceuticals Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2023-2027).
05 What are few of the challenges faced by Global Biopharmaceuticals Market?
Inflation together with drug pricing and reimbursement-related concerns will be the leading impediment to industry growth.
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.